|
TMEM194B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.842800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.770400E-01 |
| Normal-vs-Stage2 |
3.950200E-01 |
| Normal-vs-Stage3 |
1.485780E-01 |
| Normal-vs-Stage4 |
4.529800E-01 |
| Stage1-vs-Stage2 |
1.235830E-01 |
| Stage1-vs-Stage3 |
2.182000E-02 |
| Stage1-vs-Stage4 |
1.665630E-01 |
| Stage2-vs-Stage3 |
7.314200E-01 |
| Stage2-vs-Stage4 |
8.728800E-01 |
| Stage3-vs-Stage4 |
9.180400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.114800E-01 |
| Normal-vs-AfricanAmerican |
2.623400E-01 |
| Normal-vs-Asian |
5.108400E-01 |
| Caucasian-vs-AfricanAmerican |
1.900240E-01 |
| Caucasian-vs-Asian |
3.474600E-01 |
| AfricanAmerican-vs-Asian |
7.560800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.456190E-01 |
| Normal-vs-Female |
2.061000E-03 |
| Male-vs-Female |
3.8714999999967E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.675200E-01 |
| Normal-vs-Extreme_Weight |
7.844400E-02 |
| Normal-vs-Obese |
2.742800E-01 |
| Normal-vs-Extreme_Obese |
6.110000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.438200E-01 |
| Normal_Weight-vs-Obese |
8.081700E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.974600E-01 |
| Extreme_Weight-vs-Obese |
1.888260E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.064800E-01 |
| Obese-vs-Extreme_Obese |
9.037600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.613900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.971800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.465400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.390600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.619600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.384700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.246100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.544200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.253800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.591000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.749000E-01 |
| Normal-VS-Type2 PRCC |
9.774200E-01 |
| Normal-VS-KIRP CIMP |
1.708480E-02 |
| Normal-VS-Unclassified PRCC |
1.660420E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.376400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.65889999999403E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.644400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.482200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.100200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.809700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.772200E-01 |
| Normal-vs-N1 |
1.550210E-02 |
| Normal-vs-N2 |
6.660400E-01 |
| N0-vs-N1 |
8.278100E-03 |
| N0-vs-N2 |
3.720000E-01 |
| N1-vs-N2 |
5.792200E-01 |
|
|
